IDEAS home Printed from https://ideas.repec.org/a/gam/jecomi/v10y2022i5p112-d813776.html
   My bibliography  Save this article

Aggregate Online Brand Name Pharmacy Price Dynamics for the United States and Mexico

Author

Listed:
  • Thomas M. Fullerton

    (Department of Economics & Finance, University of Texas at El Paso, El Paso, TX 79968-0543, USA)

  • Steven L. Fullerton

    (Border Region Modeling Project, University of Texas at El Paso, El Paso, TX 79968-0543, USA)

Abstract

Virtual cross-border medical tourism allows many residents in the United States to purchase brand name medicines from companies in Mexico without travelling there. Monthly economic reports indicate that the online brand name pharmaceutical product prices in Mexico are noticeably lower than the corresponding internet prices in the United States. There have been very few econometric studies on how these prices are linked and the dynamic nature of those relationships. Results in this study indicate that online medicine prices in Mexico respond very rapidly to online prices changes in the high-price market.

Suggested Citation

  • Thomas M. Fullerton & Steven L. Fullerton, 2022. "Aggregate Online Brand Name Pharmacy Price Dynamics for the United States and Mexico," Economies, MDPI, vol. 10(5), pages 1-5, May.
    • Handle: RePEc:gam:jecomi:v:10:y:2022:i:5:p:112-:d:813776
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/2227-7099/10/5/112/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/2227-7099/10/5/112/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Francesca Barigozzi & Izabela Jelovac, 2020. "Research funding and price negotiation for new drugs," Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 83-96, October.
    2. Rahmiye Figen Ceylan & Burhan Ozkan & Esra Mulazimogullari, 2020. "Historical evidence for economic effects of COVID-19," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(6), pages 817-823, August.
    3. Thomas M. Fullerton & Omar Solis, 2020. "Borderplex Bridge Wait Time Headache Reactions," Journal of Transport Economics and Policy, University of Bath, vol. 54(1), pages 58-5-78.
    4. Thomas M Fullerton Jr & Francisco J Pallares & Adam G Walke, 2014. "Are Online Pharmacy Prices Really Lower in Mexico?," Asian Economic and Financial Review, Asian Economic and Social Society, vol. 4(4), pages 416-431.
    5. Francisco J. Pallares & Adam G. Walke & Thomas M., 2014. "Are Online Pharmacy Prices Really Lower in Mexico?," Asian Economic and Financial Review, Asian Economic and Social Society, vol. 4(4), pages 416-431, April.
    6. Sotiris Vandoros & Panos Kanavos, 2013. "The generics paradox revisited: empirical evidence from regulated markets," Applied Economics, Taylor & Francis Journals, vol. 45(22), pages 3230-3239, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Kong Juan & Kepili Ema Izati Binti Zull, 2023. "A Survey Analysis: The Current Real Estate Marketing Situation in the China Greater Bay Area in the Context of the COVID-19 Epidemic," Real Estate Management and Valuation, Sciendo, vol. 31(3), pages 1-19, September.
    2. Castanheira, Micael & Ornaghi, Carmine & Siotis, Georges, 2019. "The unexpected consequences of generic entry," Journal of Health Economics, Elsevier, vol. 68(C).
    3. Donatella Saccone, 2021. "Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(7), pages 1025-1038, September.
    4. Paul A. Schulte & Ivo Iavicoli & Luca Fontana & Stavroula Leka & Maureen F. Dollard & Acran Salmen-Navarro & Fernanda J. Salles & Kelly P. K. Olympio & Roberto Lucchini & Marilyn Fingerhut & Francesco, 2022. "Occupational Safety and Health Staging Framework for Decent Work," IJERPH, MDPI, vol. 19(17), pages 1-28, August.
    5. Sotiris Vandoros, 2014. "Therapeutic Substitution Post‐Patent Expiry: The Cases Of Ace Inhibitors And Proton Pump Inhibitors," Health Economics, John Wiley & Sons, Ltd., vol. 23(5), pages 621-630, May.
    6. Untaru, Elena-Nicoleta & Han, Heesup, 2021. "Protective measures against COVID-19 and the business strategies of the retail enterprises: Differences in gender, age, education, and income among shoppers," Journal of Retailing and Consumer Services, Elsevier, vol. 60(C).
    7. Feng, Gen-Fu & Yang, Hao-Chang & Gong, Qiang & Chang, Chun-Ping, 2021. "What is the exchange rate volatility response to COVID-19 and government interventions?," Economic Analysis and Policy, Elsevier, vol. 69(C), pages 705-719.
    8. Katharina Elisabeth Fischer & Tom Stargardt, 2016. "The diffusion of generics after patent expiry in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1027-1040, November.
    9. Laura Grassi & Simone Fantaccini, 2022. "An overview of Fintech applications to solve the puzzle of health care funding: state-of-the-art in medical crowdfunding," Financial Innovation, Springer;Southwestern University of Finance and Economics, vol. 8(1), pages 1-27, December.
    10. Wei, Runchu & Chen, Xia & Chang, Chun-Ping, 2021. "Does COVID-19 pandemic hurt stock prices of solar enterprises?," Economic Analysis and Policy, Elsevier, vol. 72(C), pages 41-57.
    11. Doran, Áine & Colvin, Christopher L. & McLaughlin, Eoin, 2024. "What can we learn from historical pandemics? A systematic review of the literature," Social Science & Medicine, Elsevier, vol. 342(C).
    12. Wei Wan & Jue Wang & Weimin Jiang, 2023. "Does COVID-19 Exacerbate Regional Income Inequality? Evidence from 20 Provinces of China," Sustainability, MDPI, vol. 15(15), pages 1-16, August.
    13. Óscar Afonso, 2023. "Inter‐ and intracountry effects of the Covid‐19 pandemic on wages and economic growth," Bulletin of Economic Research, Wiley Blackwell, vol. 75(4), pages 1291-1322, October.
    14. Costa-Font, Joan & Rudisill, Caroline & Tan, Stefanie, 2014. "Brand loyalty, patients and limited generic medicines uptake," Health Policy, Elsevier, vol. 116(2), pages 224-233.
    15. Yoo, Sunbin & Managi, Shunsuke, 2020. "Global mortality benefits of COVID-19 action," Technological Forecasting and Social Change, Elsevier, vol. 160(C).
    16. Arvate, Paulo Roberto & Barbosa, Klênio & Gambardella, Dante, 2013. "Generic-branded drug competition and the price for pharmaceuticals in procurement auctions," Textos para discussão 333, FGV EESP - Escola de Economia de São Paulo, Fundação Getulio Vargas (Brazil).
    17. Antoine Tonnoir & Ioana Ciotir & Adrian-Liviu Scutariu & Octavian Dospinescu, 2021. "A Model for the Optimal Investment Strategy in the Context of Pandemic Regional Lockdown," Mathematics, MDPI, vol. 9(9), pages 1-12, May.
    18. Kanavos, Panos, 2014. "Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States," Health Policy, Elsevier, vol. 118(2), pages 229-241.
    19. Vikkram Singh & Homayoun Shirazi & Jessica Turetken, 2022. "The COVID-19 Era—Influencers of Uneven Sector Performance: A Canadian Perspective," Economies, MDPI, vol. 10(2), pages 1-24, February.
    20. Olivier Boiral & Marie-Christine Brotherton & Léo Rivaud & Laurence Guillaumie, 2021. "Organizations’ Management of the COVID-19 Pandemic: A Scoping Review of Business Articles," Sustainability, MDPI, vol. 13(7), pages 1-20, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jecomi:v:10:y:2022:i:5:p:112-:d:813776. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.